Lundbeck
HLUN-B.CO
#2596
Rank
ยฃ4.97 B
Marketcap
ยฃ5.24
Share price
0.63%
Change (1 day)
9.61%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): ยฃ0.46

According to Lundbeck's latest financial reports the company's current EPS (TTM) is ยฃ0.46. In 2024 the company made an earnings per share (EPS) of ยฃ0.33 an increase over its 2023 EPS that were of ยฃ0.26.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.4638.17%
2024ยฃ0.3329.29%
2023ยฃ0.2623.09%
2022ยฃ0.2137.26%
2021ยฃ0.15-84.61%
2020ยฃ0.99-24.61%
2019ยฃ1.31-42.06%
2018ยฃ2.2640.7%
2017ยฃ1.61146.26%
2016ยฃ0.65-120.48%
2015-ยฃ3.193231.32%
2014-ยฃ0.09563-115.78%
2013ยฃ0.61-23.36%
2012ยฃ0.79-48.01%
2011ยฃ1.52-9.68%
2010ยฃ1.6813.72%
2009ยฃ1.4824.32%
2008ยฃ1.19-6.05%
2007ยฃ1.2781.77%
2006ยฃ0.70-16.76%
2005ยฃ0.84-17.58%
2004ยฃ1.02